178 related articles for article (PubMed ID: 27997061)
1. Use of pretreatment serum uric acid level to predict metastasis in locally advanced nasopharyngeal carcinoma.
Du XJ; Chen L; Li WF; Tang LL; Mao YP; Guo R; Sun Y; Lin AH; Ma J
Head Neck; 2017 Mar; 39(3):492-497. PubMed ID: 27997061
[TBL] [Abstract][Full Text] [Related]
2. Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma.
Chan OS; Sze HC; Lee MC; Chan LL; Chang AT; Lee SW; Hung WM; Lee AW; Ng WT
Head Neck; 2017 Mar; 39(3):533-540. PubMed ID: 27898191
[TBL] [Abstract][Full Text] [Related]
3. Prospective validation of the prognostic value of elevated serum vascular endothelial growth factor in patients with nasopharyngeal carcinoma: more distant metastases and shorter overall survival after treatment.
Lv X; Xiang YQ; Cao SM; Qian CN; Li NW; Guo L; Mai HQ; Chen QY; Huang PY; Luo D; Cao KJ; Hong MH; Guo X
Head Neck; 2011 Jun; 33(6):780-5. PubMed ID: 20967862
[TBL] [Abstract][Full Text] [Related]
4. Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis.
Zhou GQ; Tang LL; Mao YP; Chen L; Li WF; Sun Y; Liu LZ; Li L; Lin AH; Ma J
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e359-65. PubMed ID: 22000748
[TBL] [Abstract][Full Text] [Related]
5. Plasma uric acid and tumor volume are highly predictive of outcome in nasopharyngeal carcinoma patients receiving intensity modulated radiotherapy.
Lin H; Lin HX; Ge N; Wang HZ; Sun R; Hu WH
Radiat Oncol; 2013 May; 8():121. PubMed ID: 23675829
[TBL] [Abstract][Full Text] [Related]
6. Incidence of small lymph node metastases in patients with nasopharyngeal carcinoma: Clinical implications for prognosis and treatment.
Xu P; Min Y; Blanchard P; Feng M; Zhang P; Luo Y; Fan Z; Lang J
Head Neck; 2017 Feb; 39(2):305-310. PubMed ID: 27627795
[TBL] [Abstract][Full Text] [Related]
7. Magnetic Resonance Imaging-Detected Intracranial Extension in the T4 Classification Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy.
Cao C; Luo J; Gao L; Yi J; Huang X; Li S; Xiao J; Zhang Z; Xu G
Cancer Res Treat; 2017 Apr; 49(2):518-525. PubMed ID: 27554478
[TBL] [Abstract][Full Text] [Related]
8. Prognostic values of hematological biomarkers in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
Ye L; Oei RW; Kong F; Xu T; Shen C; Wang X; He X; Kong L; Hu C; Ying H
Eur Arch Otorhinolaryngol; 2018 May; 275(5):1309-1317. PubMed ID: 29589142
[TBL] [Abstract][Full Text] [Related]
9. High pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinoma.
Wan XB; Wei L; Li H; Dong M; Lin Q; Ma XK; Huang PY; Wen JY; Li X; Chen J; Ruan DY; Lin ZX; Chen ZH; Liu Q; Wu XY; Hong MH
Eur J Cancer; 2013 Jul; 49(10):2356-64. PubMed ID: 23541571
[TBL] [Abstract][Full Text] [Related]
10. Comparative study on prophylactic irradiation to the whole neck and to the upper neck for patients with neck lymph node-negative nasopharyngeal carcinoma.
Zeng L; Sun XM; Chen CY; Han F; Huang Y; Xiao WW; Liu S; Tian YM; Deng XW; Lu TX
Head Neck; 2014 May; 36(5):687-93. PubMed ID: 23606573
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment Serum Lactate Dehydrogenase Level as an Independent Prognostic Factor of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era.
Chen Z; Guo Q; Lu T; Lin S; Zong J; Zhan S; Xu L; Pan J
Med Sci Monit; 2017 Jan; 23():437-445. PubMed ID: 28120819
[TBL] [Abstract][Full Text] [Related]
12. Identifying pretreatment baseline factors predictive of distant metastasis in patients with nasopharyngeal carcinoma after radiotherapy.
Wang Y; Chen G
Medicine (Baltimore); 2017 Apr; 96(17):e6692. PubMed ID: 28445271
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy.
Lin YH; Huang TL; Chien CY; Chen HC; Hsu HC; Huang EY; Wang CJ; Huang YJ; Wang YM; Huang CC; Chou SY; Liao KC; Fang FM
Radiat Oncol; 2018 Mar; 13(1):45. PubMed ID: 29554940
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of locoregionally advanced nasopharyngeal carcinoma treated with intensity modulated irradiation and platinum-based chemotherapy.
Xu JH; Guo WJ; Bian XH; Wu JF; Jiang XS; Guo YS; He X
Cancer Radiother; 2013; 17(4):297-303. PubMed ID: 23849438
[TBL] [Abstract][Full Text] [Related]
15. Elevated plasma fibrinogen level shows superior prognostic value than Epstein-Barr virus DNA load for stage IVA/B nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era.
Lan M; Chen C; Huang Y; Mao M; Han F; Liao J; Deng M; Duan Z; Zheng L; Wu S; Lu T; Jian Y
Oncotarget; 2016 Jul; 7(29):46242-46252. PubMed ID: 27323828
[TBL] [Abstract][Full Text] [Related]
16. Elevated high-sensitivity C-reactive protein levels predict decreased survival for nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era.
Tang LQ; Hu DP; Chen QY; Zhang L; Lai XP; He Y; Xu YX; Wen SH; Peng YT; Chen WH; Guo SS; Liu LT; Qian CN; Guo X; Zeng MS; Mai HQ
PLoS One; 2015; 10(4):e0122965. PubMed ID: 25874450
[TBL] [Abstract][Full Text] [Related]
17. Influence of pretreatment ideal body weight percentile and albumin on prognosis of nasopharyngeal carcinoma: Long-term outcomes of 512 patients from a single institution.
Li G; Gao J; Liu ZG; Tao YL; Xu BQ; Tu ZW; Zhang XP; Zeng MS; Xia YF
Head Neck; 2014 May; 36(5):660-6. PubMed ID: 23606535
[TBL] [Abstract][Full Text] [Related]
18. A retrospective study of the prognostic value of MRI-derived residual tumors at the end of intensity-modulated radiotherapy in 358 patients with locally-advanced nasopharyngeal carcinoma.
He Y; Zhou Q; Shen L; Zhao Y; Lei M; Wei R; Shen L; Cao S
Radiat Oncol; 2015 Apr; 10():89. PubMed ID: 25881159
[TBL] [Abstract][Full Text] [Related]
19. Oligometastases in AJCC stage IVc nasopharyngeal carcinoma: A subset with better overall survival.
Tian YH; Zou WH; Xiao WW; Zeng L; Yuan X; Bai L; Lu T; Tian Y; Han F
Head Neck; 2016 Aug; 38(8):1152-7. PubMed ID: 27220062
[TBL] [Abstract][Full Text] [Related]
20. Prognoses and long-term outcomes of nasopharyngeal carcinoma in Han and Uyghur patients treated with intensity-modulated radiotherapy in the Xinjiang Autonomous Region of China.
Wang R; Tan Y; Wang X; Ma L; Wang D; Hu Y; Qin Y; Liu K; Chang C; Yu J
PLoS One; 2014; 9(11):e111145. PubMed ID: 25375129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
